Reaction

Mean Platelet Volume Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 820 reports · 38 co-occurring drugs

As of the last recalculation, Mean Platelet Volume Decreased appears in 820 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC POTASSIUM, FILM COATED (PRR 84.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Diclofenac Potassium, Film Coated	27	84.2	84.5
Diclofenac Potassium Tablets	27	84.1	84.4
Diclofenac Potassium	27	65.5	65.7
Cortisone Acetate	29	61.8	61.9
Ado-Trastuzumab Emtansine	20	61.7	61.8
Calcium Gluconate	28	61.0	61.2
Adalimumab-Fkjp	91	56.0	56.1
Adalimumab-Aaty	91	54.8	54.9
Adalimumab-Adaz	92	49.7	49.8
Alemtuzumab	34	46.5	46.6
Desoximetasone	33	45.8	45.8
Sulfasalazine	115	43.2	43.3
Dimenhydrinate	17	41.3	41.4
Hydroxychloroquine Sulfate	101	32.0	32.0
Leflunomide	112	31.3	31.3
Tocilizumab	117	30.2	30.2
Pertuzumab	31	30.0	30.1
Abatacept	113	23.9	23.9
Diclofenac Sodium 1%	32	23.6	23.6
Diclofenac Sodium Topical	32	23.6	23.6
Diclofenac Sodium Topical Gel, 1%	32	23.6	23.6
Pseudoephedrine Hydrochloride	9	22.5	22.5
Fesoterodine Fumarate	9	21.3	21.3
Pseudoephedrine Hcl	9	21.0	21.0
Felodipine Extended-Release Tablets	9	20.3	20.3
Felodipine	9	20.3	20.3
Niraparib	16	18.6	18.7
Infliximab	132	18.1	18.1
Cetirizine Hydrochloride Allergy	20	17.2	17.2
Cetirizine Hydrochloride Tablets	20	17.2	17.2
Eculizumab	34	16.5	16.5
Ravulizumab	8	15.2	15.2
Trastuzumab	38	14.7	14.7
Clozapine	66	14.4	14.4
Prochlorperazine	15	14.0	14.0
Asfotase Alfa	5	12.7	12.7
Tofacitinib Citrate	6	11.7	11.7
Palbociclib	31	8.5	8.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.